Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a...
9 insider purchases on record · latest filing 2026-08-18.
Insiders have also filed 1 sale transaction at ASND.